Watchlist
Loading...
US Stock MarketDetailed Quotes

FGEN FibroGen

Watchlist
0.620 +0.005+0.75% Close 12/08 16:00 ET
0.6200.0000.00% Post 16:02 ET
0.649High0.586Low774.25KVolume
Full Hours
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About FibroGen Company

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Revenue Breakdown

Business Currency:USD
2022/12/31
Stock NameRevenueRatio
Product revenue, net82.87M58.88%
Development and other revenue24.19M17.19%
License revenue22.59M16.05%
Drug product revenue, net11.09M7.88%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >